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Objectives: Serum or plasma microRNAs (miRNAs) are potential biomarkers for
the diagnosis for cancer and prenatal diseases. This study was conducted to
investigate whether rabies virus causes a change in serum miRNA expression.
Methods: ICR mice were intramuscularly inoculated with rabies virus and were
sacrificed weekly to collect serum and brain tissue for 4 weeks postinoculation.
Mice were assigned to four groups based on the results of indirect immunofluo-
rescent assays, enzyme-linked immunosorbent assay, and nested reverse
transcription-polymerase chain reaction and the expression profiles of serum
miRNAs were compared using a commercial mouse miRNA expression profiling
assay.
Results: The expression levels of miRNAs changed significantly with the different
stages of the disease. The expression level of 94 serum miRNAs in infected mice
changed at least twofold. Seven microRNAs of them were significantly upregu-
lated or downregulated in all infected mice regardless of disease status. The
number of miRNAs with an expression level change decreased with the
progression of the disease. In a hierarchical cluster analysis, infected mice
clustered into a group separate from uninfected control mice.
Conclusions: Based on the relationship of miRNAs to gene expression regulation,
miRNAs may be candidates for the study of viral pathogenesis and could have
potential as biomarkers.1. Introduction
Rabies virus is a negative-stranded RNA virus of the
family Rhabdoviridae and the genus Lyssavirus, and the
cause of rabies, a fatal neurological disease in humansibuted under the terms o
y-nc/3.0) which permits un
is properly cited.
ase Control and Preventionand animals [1]. Although rabies can be deadly, the
disease is preventable by preexposure immunization and
by the timely and appropriate application of postexposure
prophylaxis [2]. Reverse transcription-polymerase chain
reaction (RT-PCR), immunohistochemical staining, andf the Creative Commons Attribution Non-Commercial License
restricted non-commercial use, distribution, and reproduction in
. Published by Elsevier Korea LLC. All rights reserved.
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virus from skin biopsy, cornea, saliva, urine, and cere-
brospinal fluid for intra vitam diagnosis and from brain
tissue for postmortem diagnosis [3]. Rapid fluorescent
focusing inhibition test, enzyme-linked immunosorbent
assay (ELISA), and indirect immunofluorescent assay
(IFA) have been widely used for the serologic diagnosis
of rabies. Rabies virus-specific antibodies have been
detected in the late phase of infection and at the terminal
stage of the disease using these procedures [4].
MicroRNAs (miRNAs) are highly conserved, non-
coding, small RNAs of approximately 22 nucleotides
that regulate gene expression posttranscriptionally by
facilitating translational repression or mRNA degrada-
tion [5,6]. miRNAs play important roles in the control of
many biologic processes such as development, metab-
olism, cellular differentiation, proliferation, cell-cycle
control, and cell death [7,8]. miRNA-specific expres-
sion profiles have been reported for several pathogenic
conditions, such as viral infections, cancer, and cardio-
vascular disease [7,9]. Thus, disease-associated miRNA
may be a viable target for the development of diagnostic
markers.
The fatal outcome of rabies may be due to a neuronal
dysfunction of infected neurons [10,11]. In this study, it
was hypothesized that miRNAs may be involved in
alternation or change of neuronal functions and that
infection with rabies virus may be initially evident as
altered miRNA expression. To begin to examine this
hypothesis, the current pilot study investigated whether
rabies virus infection could lead to a change in the
expression of serum miRNAs.2. Materials and Methods
2.1. Rabies viruses
The rabies virus KGH strain was isolated from
a patient bitten by a rabid raccoon dog (Nyctereutes
procyonoides) in Korea in 2001. The supernatant of
homogenized skin tissue from the nape of the patient’s
neck was inoculated intracerebrally into suckling mice.
The brain tissue of mice was collected when clinical
signs of the disease developed (6e7 days after inocu-
lation) and stored at 70C until use. The 50% lethal
dose (LD50) of KGH strain was determined in 5-week-
old female ICR mice using the stored brain tissue. The
supernatant of the brain tissue was serially diluted
10-fold with phosphate-buffered saline (pH 7.4). Five
mice for each dilution were inoculated intramuscularly
in the femoral region of the mice. Clinical signs were
observed daily for 12 weeks after inoculation (wpi).
2.2. Experimental design
The protocol of the animal experiments was
approved by the Animal Care and Use Committee of the
National Institute of Toxicological Research on behalfof Korea Centers for Disease Control and Prevention
(#NIH-08-14). Female, 5e6-week-old ICR mice
(Samtako, Osan, Korea) were reared in Iso cages in
a Biosafety Level 3 facility. They had access to food and
water ad libitum. Control and experimental mice were
inoculated intramuscularly in a femoral region with
phosphate-buffered saline (pH 7.4) and with 102.9 LD50
of the KGH strain, respectively. Brain tissue and blood
of mice were collected weekly from 0 to 4 wpi for
serologic and molecular assays. When moribund, mice
were sacrificed to sample brain tissue and blood
regardless of experimental schedule. Serum obtained
was divided into aliquots and stored at e70C for
serologic assays and miRNA extraction. Nested RT-PCR
was used to detect the virus from brain tissue and serum.
All surviving mice were sacrificed on 12 wpi for
sampling.
2.3. Serologic assays
Rabies antibodies were analyzed using IFA and
ELISA. To prepare slides for IFA, baby hamster kidney
cells were infected with the ERA strain of rabies virus
for 1 hour and incubated for 45e48 hours at 37C. After
incubation, the cells were treated with trypsin-EDTA
solution and resuspended in Eagle minimum essential
medium (1 x 104 cells/mL). The cells were dispensed
into wells of an eight-well slide glass (Lab-Tek
Chamber Slide, Nalgen Nunc International, Rochester,
NY, USA) and incubated 5e6 hours to allow cells to
attach to the slide. Adherent cells were fixed with cold
acetone for 10 minutes and kept at 20C until further
use. For IFA, 20 mL of serum diluted 1:16 was loaded in
each well of another slide and incubated for 30 minutes
at 37C. Goat anti-mouse immunoglobulins G and M
antibodies conjugated with fluorescein isothiocyanate
(FITC; Jackson Immunoresearch Laboratories, West
Grove, PA, USA) were treated in the same manner.
FITC signal was observed with a fluorescent microscope
(Carl Zeiss, Oberkochen, Germany). PLATELIA
RABIES II kit (Bio-Rad, Marnes-la-Coquette, France)
was used for ELISA. Mouse serum was diluted 1:100
with the sample diluent included in a kit following the
manufacturer’s protocol.
2.4. RNA extraction
Viral RNA was extracted from 100 mL of 10% tissue
homogenate and 200 mL serum using RNeasy Plus Mini
Kit (Qiagen, Hilden, Germany) and Trizol reagent
(Invitrogen, Carlsbad, CA, USA), respectively. Extrac-
ted RNAs were resuspended in RNase-free distilled
water. RNAs extracted from the brain tissue were used
to determine virus infection. Before miRNA expression
profiling, the concentration and quality of serum RNAs
were measured using a Nanodrop ND-100 spectropho-
tometer (NanoDrop, Wilmington, DE, USA) and
a model 2100 bioanalyzer (Agilent, Santa Clara, CA,
USA).
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A nested one-step RT-PCR was designed to amplify
the nucleoprotein gene of rabies virus. Forward and
reverse primers were composed of forward primer
RVND-F1 (50-ctacaatggatgccgac-30) and reverse primer
RVND-R1 (50-cgaatatgtcttgtttagaaactcg-30) for one-
step RT-PCR, and forward primer RVND-F2 (50-
gacatgtccggaagactgg-30) and reverse primer RVND-R2
(50-gtattgcctctctagcggtg-30) for nested polymerase chain
reaction (PCR). For one-step RT-PCR, 5 mL of extracted
RNA were mixed with a RT-PCR mixture consisting of
5 uL 10 PCR buffer (50 mM KCl, 10 mM Tris-HCl
[pH 9.0], 0.1% Triton X-100), 5 mL 25 mM MgCl2,
2 mL 25 mM deoxynucelotide triphosphates, 1 mL of
each primer (10 mM), 1 mL Taq DNA polymerase (5
U/mL), 0.5 mL RNaseOut RNase inhibitor (40 U/mL),
and 0.5 mL SuperScript III reverse transcriptase (200
U/mL) in total volume of 50 mL. The conditions of the
one-step RT-PCR were one cycle of 50C for 60
minutes and 95C for 5 minutes; 35 cycles of 94C for
30 seconds, 55C for 30 seconds, and 72C for 80
seconds; and one cycle of 72C for 10 minutes. Nested
PCR was performed with 1 mL of RT-PCR product and
the same RT-PCR mixture composition without RNase
inhibitors and reverse transcriptase. The conditions of
the nested PCR was one cycle of 95C for 5 minutes; 35
cycles of 94C for 30 seconds, 55C for 30 seconds, and
one cycle of 72C for 80 seconds; and 72C for 10
minutes. Amplified nested RT-PCR products were
electrophoresed in 1.2% agarose gel containing 0.25%
bromophenol blue and 0.25% xylene cyanol FF.
2.6. Analysis of miRNAs expression profiling
Mice for miRNA expression profiling analysis were
assigned to four groups based on the results of IFA,
ELISA, and nested RT-PCR (Table 1). The expression
levels of serum miRNAs were measured using a mouse
miRNA expression profiling assay (Illumina, Inc., San
Diego, CA, USA). The assay panel contains 380 assays
for mouse miRNAs described in the miRBase database
v9.1. According to the manufacturer’s instructions,
miRNAs were polyadenylated and converted toTable 1. Mouse groups classified by the results of serologic and
profilea
Group Identification number of mouse
Control 0W4, 0W8, and 0W10
1A 1W8
1B 1W3, 1W6, 2W6, and 2W7
1C 1W4, 2W4, 2W4, 2W5, 2W8, 3W1, and 3W2
2A 1W3, 1W6, 2W6, and 2W7
2B 1W4, 2W4, and 2W8
2C 2W5, 3W1, and 3W2
aRabies virus was only detected from brain tissues of some inoculated mice, no
ELISAZ enzyme-linked immunosorbent assay; IFAZ indirect immunofluoresccomplementary DNA after hybridization with miRNA-
specific oligos and PCR-amplified. BeadStudio v3.1.3
(Illumina) was used to extract the array data. The signal
value was log transformed and normalized by the
quantile method. Hierarchical clustering was used to
determine similarity using complete linkage and
euclidean distance. miRNAs with at least a twofold
difference in expression level in inoculated mice
compared to uninoculated control mice were selected to
determine the expression profile.3. Results
3.1. Serologic assays, virus detection, and
clinical signs
Each mouse was given an identification number,
which was combined with group and individual
numbers. The first digit and letter indicated the week of
sampling collection after inoculation (e.g., 1 W denoted
1 week after inoculation) and the last digit denoted the
individual number. Signs such as depression, ruffled fur,
and tremors were present in mice 2W4, 2W5, 3W1, and
3W2. Mice 1W4 and 2W4 were positive for rabies
antibodies by IFA but not by ELISA. Rabies antibodies
were detected in mice 2W5, 3W1, and 3W2 by both IFA
and ELISA (Table 1). Mouse 1W8 was serologically
negative for the rabies virus. Rabies virus was detected
in brain tissue of mice 1W4, 2W4, 2W5, 2W8, 3W1, and
3W2 by nested one-step RT-PCR (Table 1). However,
rabies virus was not detected in sera of any mice,
including uninoculated control mice. All uninoculated
control mice (0W4, 0W8, and 0W10) were negative for
rabies antibody and for virus.
3.2. Expression levels of serum miRNAs
Inoculated mice were divided into two groups based
on the results of serologic and molecular assays to
compare the expression profiling of serum miRNAs with
three uninoculated control mice (Table 1). Mouse 1W8
was selected for analysis of miRNA expression profile
because it was serologically and virologically negativemolecular assays for comparing serum microRNA expression
Results of assays
IFA ELISA Nested RT-PCRa
Negative Negative Negative
Negative Negative Negative
Positive Negative Negative
Positive Positive or negative Positive
Positive Negative Negative
Positive Negative Positive
Positive Positive Positive
t from serum by nested RT-PCR.
ent assay.
Figure 1. Expression profiling of serum miRNAs in mice
inoculated with rabies virus KGH strain. miRNAs with at least
a twofold change of expression level are denoted in the Venn
diagram. Digits in the Venn diagram indicate the change in the
miRNA expression level of each group and between groups.
(A) Groups assigned based on results of IFA and nested RT-
PCR. (B) Groups assigned based on the results of IFA,
ELISA, and nested RT-PCR.
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zation of data, 352 of the 380 miRNAs were selected
for analysis of miRNA expression profiling. miRNAs
with upregulated or downregulated expression are
summarized (Figure 1). miRNA expression profiles
were categorized into two major groups (Groups 1 and
2) based on IFA, ELISA, and nested RT-PCR results.
Each major group was also subdivided into three
subgroups (A, B, and C). First, Group 1 was classified
by IFA and nested RT-PCR results as follows: 1W8 for
Group 1A; 1W3, 1W6, 2W6, and 2W7 for Group 1B;
and 1W4, 2W4, 2W5, 2W8, 3W1, and 3W2 for Group
1C. The expression levels of 94 serum miRNAs changed
at least twofold in mice inoculated with rabies virus, and
all but two miRNAs were downregulated or upregulated
regardless of the groups. Two miRNAs, mmu-miR-701
and mmu-miR-142-5 p, were downregulated in group
1A but were upregulated in group 1B. Expression
levels of six miRNAs (mmu-miR-98, mmu-miR-100,
mmu-miR-187, mmu-miR-322, mmu-miR-466, and
mmu-miR-707) changed significantly in all inoculated
mice, and the expression levels of three miRNAs
(mmu-miR-98, mmu-miR-466 and mmu-miR-706) wereFigure 2. Mean change of serum miRNAs in the inoculated grou
were assigned to (A) Group 1 or (B) Group 2 based on the resultsdownregulated. Expression levels changed in 57 and 9
miRNAs in Groups 1B and 1C, respectively. Mouse
1W8 displayed altered expression of 68 miRNAs. Of the
68 miRNAs, 25 and 2 miRNAs also changed expression
levels in Groups 1B and 1C, respectively.
Group 2 was divided based on the results of IFA,
ELISA, and RT-PCR as follows: 1W3, 1W6, 2W6, and
2W7 for Group 2A; 1W4, 2W4, and 2W8 for Group 2B;
2W5, 3W1, and 3W2 for Group 2C (Figure 2). Mouse
1W8 was excluded from Group 2. As shown in
Figure 2B, 69 miRNAs in serum of all groups displayed
altered expression levels compared with uninoculated
control mice. Among these, the expression of 19, 8 and
2 miRNAs were upregulated or downregulated only in
Groups 2A, 2B, and 2C, respectively. The average
expression levels of mmu-miR-130b and mmu-miR-
142-50 increased 3.71- and 3.19-fold in Group 2A
(p< 0.04 and p< 0.02) and mmu-let-7c, mmu-let-7f,
mmu-let-7e, mmu-miR-346, and mmu-miR-546 were
significantly down-regulated in Group 2A (p< 0.00),
suggesting that there are some miRNAs expressed in the
early stage of rabies infection. Two miRNAs (mmu-
miR-155 and mmu-miR-465-5 p) and one miRNA
(mmu-miR-103) were significantly downregulated in
Groups 2B and 2C, respectively. The expression of
mmu-miR-466 and mmu-miR-706 were significantly
decreased in all inoculated mice.
3.3. Cluster analysis
The similarity of miRNA expression profiles among
was analyzed using hierarchical clustering (Figure 3).
Mice were divided into two major clusters based on
expression pattern similarity. Uninoculated control mice
grouped with mouse 1W8, which was serologically and
clinically normal, and mice 3W1 and 3W2, which
showed signs of the terminal stage of the disease. All
other inoculated mice clustered together. Mice 1W3,
1W6, and 2W7, which were negative for antibody but
positive for virus, clustered closely with each other.
Mice 1W4 and 2W5, which were positive for bothps compared with that of the uninoculated control group. Mice
of serologic assays and nested RT-PCR.
Figure 3. Hierarchical clustering analysis of miRNA expression using euclidean method and complete linkage. The degree of
relatedness of expression profiling is represented at the top of the panel. The color and intensity in each cell indicate the expression
level of the corresponding miRNAs. The increased intensity of red and green indicates higher and lower expression of miRNAs,
respectively.
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mice.4. Discussion
miRNAs play pivotal roles in gene regulation. The
expression of a third of human genes is predicted to be
controlled by miRNAs [12]. Upregulated or down-
regulated expression of miRNAs is related to several
diseases including cancers, cardiovascular diseases,neurologic diseases, and immunologic diseases [9,13].
Because of the correlation of miRNA expression
levels with disease, miRNAs have been explored as
biomarkers for the diagnosis of diseases and as thera-
peutic targets [14,15].
Circulating cell-free nucleic acids were first detected
in plasma of healthy individuals and patients and also
from patients with pancreatic cancer and rheumatoid
arthritis [16]. The release of nucleic acids into the
general circulation has been suggested to be associated
with blood-brain barrier rupture, necrosis, apoptosis, and
Serum microRNA expression profiling in mice 191lysis of cells, placental and fetal cells, and secretory
exosomes [17,18]. However, the origin of serum nucleic
acids including miRNAs remains incompletely
understood.
Rabies virus causes neuronal dysfunction, which may
be mediated by impairment of neurotransmitter release
or ion homeostasis, rather than by neuronal death or
pathological damage of organs [19,20]. We hypothe-
sized that miRNAs may be involved in the regulation of
genes that encode neurotransmitter proteins and that the
expression profiles of miRNAs differ in different
infection stages. In this study, mouse groups had distinct
expression patterns depending on the stage of infection.
Mouse 1W8 was negative to both rabies antibody and
virus. However, the mouse had a different miRNA
expression pattern from uninoculated mice of the control
group. The pattern was closely related to mice 3W1
and 3W2. In mouse 1W8, of the 352 miRNAs, 35 had
more than a twofold change of expression level. These
results indicate that mouse 1W8 was infected with
rabies virus. Whether miRNA patterns in mouse 1W8
indicate the early stage of infection was not clear in
the current study due to a limited number of mice
examined. New research approaches will be critical to
determine miRNA expression profiles in the early stage
of infection.
The miRNAs upregulated or downregulated in one
group had the same pattern in the other group, regardless
of the inclusion of mouse 1W8. This result suggested
that there was a specific miRNA expression profile in
infected mice. The expression of six miRNAs was
specific to the infected mice, regardless of infection
stage. These miRNAs may have potential as diagnostic
biomarkers for rabies. The current study investigated
serum miRNA expression patterns of mice infected with
rabies virus. miRNAs that displayed upregulated or
downregulated expression could have potential as
biomarkers for the development of additional diagnostic
assays of rabies.Acknowledgements
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